Tokyo, Jan. 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060501) titled 'Study on the inter-individual variability of venetoclax blood concentrations and its association with efficacy and safety' on Jan. 28.
Study Type:
Observational
Primary Sponsor:
Institute - Kyoto University
Condition:
Condition - Acute Myeloid Leukemia
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - The primary objective of this study is to identify factors contributing to the inter-individual variability of venetoclax trough levels in patients with acute myeloid leukemia (AML). Specifically, we aim to analyze the impact of concomitant medications (such as CYP...